Pioneering research on ALS muscle disease rewarded

Leuven - Amyotrophic Lateral Sclerosis (ALS) is an incurable paralyzing neurodegenerative disorder that strikes five out of every 100,000 persons. The disease usually affects healthy people in the most active period of their lives - without warning or previous family history. Researchers from VIB (the Flanders Interuniversity Institute for Biotechnology), under the direction of Prof. Peter Carmeliet (K.U.Leuven), have been the first to demonstrate the importance of the VEGF protein in this disease. This research is opening prospects for treating ALS, and these promising results are highly appreciated by the persons concerned. The patient organization, ALS Association, has just presented 3000 of collected funds to Peter Carmeliet's team; and Diether Lambrechts and Erik Storkebaum, also members of Prof. Carmeliet's research team, have received the Galenus Prize to the value of 6200.

Incurable muscle disease

ALS can strike anyone. The Chinese leader Mao Tse Tung, the Russian composer Dimitri Sjostakowitz, the legendary New York Yankee baseball player Lou Gehrig, and astrophysicist Stephen Hawking have all been afflicted with ALS. In addition, an unusually large number of top Italian soccer players, airline pilots, and soldiers from the Golf war have been stricken by this fatal disease. About half of them die within three years - some even in the first year - usually as a consequence of asphyxiation, while still 'in full possession of their faculties'.

In a patient with ALS, the nerve bundles that run to the muscles deteriorate. The patient then loses control over his muscles, progressively becoming totally paralyzed, while remaining - disconcertingly - mentally sound. The causative mechanism of this grave, debilitating disease - which has an enormous medico-social impact - remains obscure. At present, the disease is totally untreatable. The consequence is that many ALS patients elect for euthanasia, a very controversial solution. Genetic r

Contact: Sooike Stoops
VIB, Flanders Interuniversity Institute of Biotechnology

Page: 1 2

Related biology news :

1. Pioneering research on sleeping sickness wins MERIAL Award for Parasitology
2. Pioneering approach to wastewater treatment earns Stanford engineer the 2007 Stockholm Water Prize
3. Pioneering researcher Dr. Kenneth Lyons Jones receives genetics award from March of Dimes
4. Pioneering research into health benefits of beauty treatment
5. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
6. Pioneering PET/CT research widens applications of imaging for diabetic foot
7. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
8. Saudi Arabias KAUST names WHOI first research partner
9. Multinational research: protecting ecology means understanding people, too
10. Newly created cancer stem cells could aid breast cancer research
11. Carnegie Mellons Peter Adams receives EPA research grant

Post Your Comments:

(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) ... research organisation (CRO) market. The trend of outsourcing ... lower margins but higher volume share for the ... and scale, however, margins in the CRO industry ... (CRO) Market ( http://www.frost.com/sublib/display-report.do?id=P86A-01-00-00-00&src=PR ), finds that ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... 24, 2015 SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
Breaking Biology Technology:
Cached News: